Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-053-2 | CAS number: 52628-03-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP/Guideline Study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, phosphate
- EC Number:
- 258-053-2
- EC Name:
- 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, phosphate
- Cas Number:
- 52628-03-2
- Molecular formula:
- C6 H10 O3 . x H3 O4 P
- IUPAC Name:
- 2-(methacryloyloxy)ethyl phosphate
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): Reaction product of 2-Hydroxyethyl methacrylate (HEMA) with Polyphosphoric Acid (PPA)
- Physical state: Yellow clear liquid
- Lot/batch No.: A022C73001
- Expiration date of the lot/batch: August 20, 2014
- Stability under test conditions: Test substance was expected to be stable for the duration of testing.
- Storage condition of test material: The test substance was stored at room temperature void of direct sunlight.
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Received from Harlan Laboratories, Indianapolis, IN
- Age at study initiation: 10-11 weeks
- Weight at study initiation: 19.2-25.0 grams
- Housing: The animals were individually housed in plastic solid bottom cages with
bedding during the dosing and resting phases of the study. After final weighing until
sacrifice, animals were housed in their respective dose groups in plastic cages with
bedding.
- Diet (e.g. ad libitum): Harlan Teklad Certified Global 16% Protein Rodent Diet® #2016C. The diet
was available ad libitum.
- Water (e.g. ad libitum): Filtered tap water was supplied ad libitum by an automatic water dispensing
system.
- Acclimation period: 14-28 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-22ºC
- Humidity (%): 45-65%,
- Air changes (per hr): 13
- Photoperiod (hrs dark / hrs light): 12-hour light/dark cycle
IN-LIFE DATES: September 19 - October 9, 2012
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Concentration:
- 10%, 25% and 50%
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
Nine test substance concentrations and the vehicle control were used for preliminary toxicity
testing. Test substance concentrations of 75%, 50%, 25%, 10%, 5%, 2.5%, 1%, 0.5% and 0.2%
in propylene glycol were tested to determine the highest achievable level that avoids overt
systemic toxicity and excessive local irritation. The top dose of 75% was selected based on
maximum solubility, compatibility, and viscosity of the test substance with the vehicle while
maintaining a pipettable solution that could be applied to the mouse ear (documented in the raw
data). Each group consisted of one mouse. The ears of each
mouse were scored for erythema and edema prior to dosing on Days 1, 2, 3, and prior to
termination on Day 6. Twenty-five microliters (25 µL) of the appropriate dilution of the test substance concentration or
the vehicle alone was applied to the dorsum of both ears of each mouse (50 L total) for three
consecutive days. Application was done using an appropriate size micropipette
to accurately deliver 25 µL. The dose was gently spread as evenly as possible over the dorsal
surface of the ear using the tip of the pipette. No treatment was made on Days 4 and 5. On Days
1, 2, 3 and 6, each site was evaluated for local irritation (erythema & edema).
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: Any test
material that produces a SI > 3 in the LLNA is normally considered “positive” for dermal
sensitization potential.
TREATMENT PREPARATION AND ADMINISTRATION:
Dilutions of the test substance were prepared as w/w mixtures in propylene glycol.
Concentrations of 10%, 25% and 50% were selected for the main test based on results of the
preliminary screening test. A single concentration of a 25% w/w mixture of HCA in propylene
glycol was prepared as a positive control. All dosage preparations were freshly prepared on the
day of administration.
Beginning on Day 1, a volume of 25 µL of the vehicle, the appropriate test substance
concentration, or the positive control substance was applied to the dorsum of both ears of each
mouse (50 µL total) once per day for three consecutive days (Days 1, 2, and 3) using a
micropipette. During application, the material was gently spread as evenly as possible over the
dorsal surface of the ear using the tip of the pipette. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Statistical analysis was performed on the body weight, body weight gain and dpm values.
Significance was judged at p <0.05. The treated group and vehicle control group were compared
using a One-Way Analysis of Variance (ANOVA), followed by comparison of the treated groups
to the vehicle control group by Dunnett’s t-test for multiple comparisons. Where variances are
considered significantly different by Bartlett’s test, groups were compared using a non-parametric
method (Kruskal-Wallis non parametric analysis of variance followed by Dunn’s test) (INSTAT
Biostatistics, Graph Pad Software, San Diego, CA). Outlier analysis was conducted using Grubbs
(1969).
Results and discussion
- Positive control results:
- HCA elicited a proliferative response with a SI value of 6.27 relative to vehicle controls.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: Group 2 (positive control) - 6.27 Group 3 (10%) - 1.34 Group 4 (25%) - 2.33 Group 5 (50%) - 3.57
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Group 1 (control) - 1852.28 ± 282.41 Group 2 (positive control) - 11605.91 ± 1945.93 Group 3 (10%) - 2491.27 ± 792.94 Group 4 (25%) - 4311.31 ± 1360.50 Group 5 (50%) - 6617.63 ± 1502.58
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: other: ECETOC 2003
- Conclusions:
- Based on the results of this study, Reaction product of 2-Hydroxyethyl methacrylate (HEMA)
with Polyphosphoric Acid (PPA) is considered positive for dermal sensitization potential in the
LLNA, with an EC3 value of 39%, which is consistent with weak sensitization potential as
described by an expert panel (ECETOC 2003). - Executive summary:
Based on the results of the screening assay, 10%, 25% and 50% w/w concentrations in propylene glycol and the vehicle alone were evaluated in the main study. All mice appeared active and healthy, and there were no consistent treatment-related effects on body weight over the course of the study. Very slight erythema was noted at two sites at the 10% concentration (Group 3) on Days 2 or 3 and most sites at the 25% concentration (Group 4) between Days 2 and 6. At the 50% concentration (Group 5), very slight to well-defined erythema was evident at most sites between Days 2 and 6, and slight edema was noted at three sites with desquamation and/or alopecia present at all sites on Day 6. No dermal irritation was observed at any site in the vehicle control group (Group 1). Very slight to well-defined erythema and slight to marked edema was noted in the positive control group (Group 2). Treatment of mice with 10%, 25% and 50% of Reaction product of 2-Hydroxyethyl methacrylate (HEMA) with Polyphosphoric Acid (PPA) resulted in stimulation index values of 1.34, 2.33 and 3.57, respectively, relative to vehicle control mice. As a stimulation index (SI) of greater than 3.0 was observed, Reaction product of 2-Hydroxyethyl methacrylate (HEMA) with Polyphosphoric Acid (PPA) was considered positive for dermal sensitization potential in the LLNA. The EC3 value calculated for the test substance was 39%, which is consistent with weak sensitization potential as described by an expert panel (ECETOC 2003). Proper conduct of the LLNA was
confirmed via a positive response with 25% HCA, a moderate contact sensitizer, which elicited a proliferative response with a SI value of 6.27 relative to vehicle controls.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.